Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis

The Cochrane Database of Systematic Reviews
Diana A FreitasKarla M P P Mendonça

Abstract

Postural drainage is used primarily in infants with cystic fibrosis from diagnosis up to the moment when they are mature enough to actively participate in self-administered treatments. However, there is a risk of gastroesophageal reflux associated with this technique. To compare the effects of standard postural drainage (greater (30° to 45° head-down tilt) and lesser (15° to 20° head-down tilt)) with modified postural drainage (greater (30º head-up tilt) or lesser (15º to 20º head-up tilt)) with regard to gastroesophageal reflux in infants and young children up to six years old with cystic fibrosis in terms of safety and efficacy. We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Cystic Fibrosis Trials Register. We also searched the reference lists of relevant articles and reviews. Additional searches were conducted on ClinicalTrials.gov and on the WHO International Clinical Trials Registry Platform for any planned, ongoing and unpublished studies.The date of the most recent literature searches: 20 January 2015. We included randomised controlled studies that compared two postural drainage regimens (standard and modified postural drainage) with regard to gastroesophageal reflux in infants and young children ...Continue Reading

References

May 1, 1991·Archives of Disease in Childhood·S CucchiaraG de Ritis
Jul 13, 1994·JAMA : the Journal of the American Medical Association·D MoherG A Wells
Feb 1, 1997·Archives of Disease in Childhood·B M ButtonA Olinsky
Apr 16, 1998·Archives of Disease in Childhood·R G HeineA G Catto-Smith
Sep 4, 1998·Journal of Paediatrics and Child Health·B M ButtonP D Phelan
Mar 27, 2002·International Journal of Epidemiology·Diana R ElbourneAndy Vail
Mar 29, 2002·Pediatric Pulmonology·Michael Robinson, Peter T B Bye
Feb 5, 2003·Pediatric Pulmonology·David M Orenstein
Feb 5, 2003·Pediatric Pulmonology·Brenda M ButtonIan Story
Apr 23, 2004·Archives of Disease in Childhood·B M ButtonA Olinsky
Jan 28, 2005·The Cochrane Database of Systematic Reviews·E MainC Schans
Apr 29, 2009·Acta Paediatrica·Badriul HegarYvan Vandenplas
Dec 8, 2009·Journal of Pediatric Gastroenterology and Nutrition·K BlondeauD Sifrim
Mar 26, 2010·BMC Medicine·Kenneth F SchulzUNKNOWN CONSORT Group
May 19, 2010·Child and Adolescent Psychiatric Clinics of North America·Michelle M ErnstLori J Stark
Jan 14, 2012·Pediatric Pulmonology·Michael DoumitYvonne Belessis
Apr 25, 2012·Current Gastroenterology Reports·Hayat M Mousa, Frederick W Woodley
Sep 24, 2013·The Cochrane Database of Systematic Reviews·Gabriela S S ChavesKarla M P P Mendonca

❮ Previous
Next ❯

Citations

Apr 24, 2018·The Cochrane Database of Systematic Reviews·Diana A FreitasKarla Mpp Mendonça
Sep 14, 2018·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jerome CarpenterRichard Superfine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.